Showing results (2851-2860 of 3,755) with videos related to
Sort By:
Pageof 376
Genes & Development|September 20, 2000
Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1B O Petersen, C Wagener, F Marinoni, et al.Diabetes|November 28, 2001
PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistanceM Guerre-Millo, C Rouault, P Poulain, et al.The Journal of Biological Chemistry|August 10, 2001
Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse linesT E Akiyama, C J Nicol, C Fievet, et al.British Journal of Anaesthesia|August 1, 2021
Selective mitochondrial antioxidant MitoTEMPO reduces renal dysfunction and systemic inflammation in experimental sepsis in ratsNishkantha Arulkumaran, Sean J Pollen, Robert Tidswell, et al.Physical Chemistry Chemical Physics : PCCP|March 29, 2019
Energy- and conformer-dependent excited-state relaxation of an E/Z photoswitchable thienyl-etheneJamie D Young, Chana R Honick, Jiawang Zhou, et al.Water Research|February 18, 2014
Quantification of continual anthropogenic pollutants released in swimming poolsM G A Keuten, M C F M Peters, H A M Daanen, et al.Journal of Clinical Periodontology|January 1, 1995
The relationship of beta-glucuronidase activity in crevicular fluid to probing attachment loss in patients with adult periodontitis. Findings from a multicenter studyI B Lamster, L G Holmes, K B Gross, et al.American Journal of Nephrology|September 1, 2016
Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney DiseaseDebbie Zittema, Irina B Versteeg, Ron T Gansevoort, et al.Archives of Physical Medicine and Rehabilitation|August 12, 2011
An intensive intervention for improving gait, balance, and mobility in individuals with chronic incomplete spinal cord injury: a pilot study of activity tolerance and benefitsStacy L Fritz, Angela M Merlo-Rains, Erin D Rivers, et al.Digestive Diseases and Sciences|April 27, 2012
Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitroHilbert S de Vries, Tineke de Heij, Henie M J Roelofs, et al.Pageof 376